Clinical Experience with Recombinant Human Thyrotrophin (rhTSH) in the Management of Patients with Differentiated Thyroid Cancer

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Biotherapy and Radiopharmaceuticals

• Publication date

  2000-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/cbr.2000.15.211PMID 10803328
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.

  1999influential reference
• Detection of Residual and Recurrent Differentiated Thyroid Carcinoma by Serum Thyroglobulin Measurement

  1999cited by this paper
• THERAPEUTIC CONTROVERSY The Use of Radioactive Iodine in Patients with Papillary and Follicular Thyroid Cancer

  1998cited by this paper
• Cancer incidence and mortality, 1973-1995: a report card for the U.S.

  1998cited by this paper
• Cancer statistics, 1998

  1998cited by this paper
• Papillary and follicular thyroid carcinoma.

  1998cited by this paper
• The use of radioactive iodine in patients with papillary and follicular thyroid cancer.

  1998cited by this paper
• Cancer incidence and mortality, 1973‐1995

  1998cited by this paper
• Quality-of-Life Changes in Patients with Thyroid Cancer After Withdrawal of Thyroid Hormone Therapy

  1997cited by this paper
• Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.

  1997cited by this paper
• Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.

  1997cited by this paper
• Prognostic factors for thyroid carcinoma

  1997cited by this paper
• Thyroid Remnant 131I Ablation for Papillary and Follicular Thyroid Carcinoma

  1997cited by this paper
• Follow-up of patients with thyroid carcinoma.

  1997cited by this paper
• Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects.

  1997cited by this paper
• Dynamic use of tumor markers, rationale-clinical applications and pitfalls.

  1996cited by this paper
• Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism.

  1996cited by this paper
• Tumor markers in breast cancer follow-up: a potentially useful parameter still awaiting definitive assessment. Forza Operativa Nazionale sul Carcinoma Mammario (FONCaM).

  1995cited by this paper
• Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.

  1994cited by this paper
• Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study).

  1994cited by this paper
• Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

  1994cited by this paper
• Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

  1993cited by this paper
• Recombinant human thyrotropin stimulates thyroid function and radioactive iodine uptake in the rhesus monkey.

  1992cited by this paper
• Recombinant human thyroid-stimulating hormone: initial bioactivity assessment using human fetal thyroid cells.

  1991cited by this paper
• Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells.

  1991cited by this paper
• Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer.

  1990cited by this paper
• Tumor marker kinetics in the monitoring of breast cancer

  1990cited by this paper
• SERUM THYROGLOBULIN CONCENTRATIONS AND 131I WHOLE BODY SCANS IN THE DIAGNOSIS OF METASTASES FROM DIFFERENTIATED THYROID CARCINOMA (AFTER THYROIDECTOMY)

  1980cited by this paper

• Thyroid Hormone Withdrawal versus Recombinant Human TSH as Preparation for I-131 Therapy in Patients with Metastatic Thyroid Cancer: A Systematic Review and Meta-Analysis

  2023cites this paper
• Prospects of Testing Diurnal Profiles of Expressions of TSH-R and Circadian Clock Genes in Thyrocytes for Identification of Preoperative Biomarkers for Thyroid Carcinoma

  2022cites this paper
• Radioiodine therapy in the different stages of differentiated thyroid cancer.

  2022cites this paper
• Proteomic Analysis of Iodinated Contrast Agent-Induced Perturbation of Thyroid Iodide Uptake

  2020cites this paper
• Local and Systemic Treatment of Unresectable Disease

  2017cites this paper
• Impact of age and sex on the quality of life following radioactive iodine ablation in patients with thyroid cancer

  2017cites this paper
• 2016 Revised Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Thyroid Cancer

  2016cites this paper
• Guidelines for Patients with Thyroid Nodules and Thyroid Cancer

  2016cites this paper
• Treatment of Metastatic Thyroid Cancer with Radioiodine Following Preparation by Recombinant Human Thyrotropin

  2016cites this paper
• A patient with widely fluctuating thyroid-stimulating hormone measurements.

  2014cites this paper
• Recombinant Human Thyroid-Stimulating Hormone

  2012cites this paper
• Can we interpret serum thyroglobulin results?

  2012cites this paper
• Tirotropina alfa recombinante como m étodo de estimulación en la ablación del Carcinoma Diferenciado de Tiroides

  2011cites this paper
• Updates on PET-CT and thyroid cancer

  2010cites this paper
• Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer.

  2010cites this paper
• Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management

  2009cites this paper
• Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

  2009cites this paper
• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

  2009cites this paper
• Thyroid Cancer Guidelines Task Force Disclosure Information

  2009cites this paper
• [A decade of recombinant human thyrotropin].

  2009cites this paper
• Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer.

  2008cites this paper
• Overview on the use of recombinant human thyrotropin in thyroid cancer of follicular cell origin.

  2008cites this paper
• Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce

  2006cites this paper
• [Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences].

  2006cites this paper
• Management of differentiated thyroid carcinoma with radioiodine and recombinant human TSH.

  2006cites this paper
• Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer.

  2006cites this paper
• Recombinant Human Thyrotropin-Assisted Radioiodine Therapy for Patients with Metastatic Thyroid Cancer Who Could Not Elevate Endogenous Thyrotropin or Be Withdrawn from Thyroxine

  2006cites this paper
• Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancer

  2006cites this paper
• Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma.

  2006cites this paper
• Chapter 4 Controversies in the use of radioiodine for remnant ablation and therapy of thyroid carcinoma

  2006cites this paper
• 131I Treatment of Metastatic Thyroid Carcinoma Following Preparation by Recombinant Human Thyrotropin

  2006cites this paper
• Aplicación de la TSH humana recombinante en el protocolo diagnóstico del cáncer diferenciado de tiroides

  2005cites this paper
• Cancers de la thyroïde

  2005cites this paper
• Role of 131 I in the Treatment of Well Differentiated Thyroid Cancer

  2005influential citation
• Papillary thyroid cancer: Medical management and follow-up

  2005cites this paper
• Recombinant Human Thyrotropin is Helpful in the Follow-Up and 131I Therapy of Patients with Thyroid Cancer: A Report of the Results and Benefits Using Recombinant Human Thyrotropin in Clinical Routine

  2005cites this paper
• rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

  2005influential citation
• Role of 131I in the treatment of well differentiated thyroid cancer

  2005influential citation
• [Application of recombinant human TSH in the diagnostic protocol of differentiated thyroid carcinoma].

  2005cites this paper
• A review of the potential uses for recombinant human TSH in patients with thyroid cancer and nodular goiter

  2004cites this paper
• Clinical uses of recombinant human thyrotropin

  2004cites this paper
• Recombinant human TSH in radioiodine treatment of differentiated thyroid cancer.

  2004cites this paper
• Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients

  2003cites this paper
• Modern Management of Differentiated Thyroid Cancer

  2003cites this paper
• Clinical review 156: Recombinant human thyrotropin and thyroid cancer management.

  2003influential citation
• Protocol for the Combined Diagnostic and Therapeutic Use of Recombinant Human Thyroid-Stimulating Hormone

  2003cites this paper
• Recombinant Human Thyrotropin and Thyroid Cancer Management

  2003cites this paper
• Utilidad de la TSH recombinante en el diagnóstico y tratamiento de las enfermedades tiroideas

  2003cites this paper
• Influence of body surface area on serum peak thyrotropin (TSH) levels after recombinant human TSH administration.

  2003cites this paper
• Iodine excretion during stimulation with rhTSH in differentiated thyroid carcinoma

  2003cites this paper
• TSH recombinante y determinación de tiroglobulina en el seguimiento del carcinoma diferenciado de tiroides

  2003cites this paper
• Recombinant Human Thyrotropin (rhTSH) in the Follow-Up and Treatment of Patients with Thyroid Cancer

  2003cites this paper
• Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.

  2003cites this paper
• Value of recombinant human thyrotropin in high-dose radioiodine therapy: a case report.

  2002cites this paper
• Serum thyroglobulin concentrations and (131)I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone.

  2001cites this paper
• Recombinant human thyrotropin in the management of thyroid cancer.

  2001cites this paper
• Radioiodine Ablation of Thyroid Remnants After Preparation with Recombinant Human Thyrotropin

  2001cites this paper
• Isotope imaging for metastatic thyroid cancer.

  2001cites this paper